XPH

SPDR S&P Pharmaceuticals ETF [XPH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

XPH Stock Summary

Top 10 Correlated ETFs

XPH

Top 10 Correlated Stocks

XPH

In the News

XPH Financial details

Company Rating
-
Market Cap
220.84M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.13
Dividend %
1.25%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.56%
SMA50
-9.09%
SMA100
-6.98%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
34.67-45.62
52W High
-11.24%
52W Low
+17.47%
RSI
48
Rel Volume
0.69
Avg Volume
38.57K
Volume
26.63K
Perf Week
0.2%
Perf Month
6.05%
Perf Quarter
-13.53%
Perf Half Y
-11.72%
-
-
-
-
Beta
0.66
-
-
Volatility
0.53%, 0.95%
Prev Close
0.86%
Price
39.94
Change
0.63%

XPH Financial Performance

XPH Dividend History

XPH Frequently Asked Questions

What is SPDR S&P Pharmaceuticals ETF stock symbol ?

SPDR S&P Pharmaceuticals ETF is a US stock and trading under the symbol XPH

What is SPDR S&P Pharmaceuticals ETF stock quote today ?

SPDR S&P Pharmaceuticals ETF stock price is $39.94 today.

Is SPDR S&P Pharmaceuticals ETF stock public?

Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
TL0.DE
AMZN
CMC.DE
DHR-PB
TSLA
Top Correlated ETFs
PILL
PJP
FTXH
AGNG
BMED
Top Correlated Stocks
RIGL
KYMR
ROIV
GSK
CPRX
Similar Market Cap
1557.HK
MVBF
0313.HK
DXU.TO
HGER

Company Profile

Financial Services Asset Management

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").